(Q60657203)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20223133%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

[Update of the Clinical Guidelines of the European Association of Urology on muscle-invasive and metastatic bladder carcinoma] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20223133%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

0 references

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20223133%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

A Stenzl

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20223133%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

N C Cowan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20223133%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

M De Santis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20223133%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

G Jakse

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20223133%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

M A Kuczyk

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20223133%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

A S Merseburger

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20223133%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

A Sherif

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20223133%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

J A Witjes

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20223133%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

European Association of Urology

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20223133%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

1 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20223133%20AND%20SRC:MED&resulttype=core&format=json

Actas Urológicas Españolas

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20223133%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20223133%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20223133%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

51-62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20223133%20AND%20SRC:MED&resulttype=core&format=json

Guidelines on bladder cancer

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Estimates of the cancer incidence and mortality in Europe in 2006.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Occupation and bladder cancer among men in Western Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Bladder cancer incidence and risk factors in men with prostate cancer: results from Cancer of the Prostate Strategic Urologic Research Endeavor

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

De novo muscle invasive bladder cancer: is there a change in trend?

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Hormonal and reproductive factors and the risk of bladder cancer in women

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Clinical significance of the "palpable mass" in patients with muscle-infiltrating bladder cancer undergoing cystectomy after pre-operative radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Limitations of computed tomography in the preoperative staging of upper tract urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

CT urography: definition, indications and techniques. A guideline for clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Long-term followup of a bladder carcinoma cohort: routine followup urography is not necessary.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Multivariate analysis of clinical parameters of synchronous primary superficial bladder cancer and upper urinary tract tumor.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Understanding multislice CT urography techniques: Many roads lead to Rome

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Update of urethra-sparing approaches in cystectomy in women

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

EAU guidelines on prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Clinicopathologic features of prostate adenocarcinoma incidentally discovered at the time of radical cystectomy: an evidence-based analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

MR imaging of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Bladder cancer: analysis of multi-detector row helical CT enhancement pattern and accuracy in tumor detection and perivesical staging.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Imaging in oncology from the University of Texas M. D. Anderson Cancer Center. Imaging in the diagnosis, staging, and follow-up of cancer of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

MR imaging of the male pelvis

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Multidetector computed tomography urography for diagnosing upper urinary tract urothelial tumour

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Upper abdominal lymph nodes: criteria for normal size determined with CT.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Whole-body MR imaging: evaluation of patients for metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Whole-body MR imaging of bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Can patient selection for bladder preservation be based on response to chemotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

1 reference

7 January 2021

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Does the option of the ileal neobladder stimulate patient and physician decision toward earlier cystectomy?

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Seminal sparing cystectomy and ileocapsuloplasty: long-term followup results

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Clinically significant prostate cancer found incidentally in radical cystoprostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Evaluation of the prostate peripheral zone/capsule in patients undergoing radical cystoprostatectomy: defining risk with prostate capsule sparing cystectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Lymphadenectomy with cystectomy: is it necessary and what is its extent?

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Is there an indication for frozen section examination of the ureteral margins during cystectomy for transitional cell carcinoma of the bladder?

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

1 reference

7 January 2021

Acid-base and electrolyte disorders after urinary diversion

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Surgical complications of urinary diversion

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Long-term results of standard procedures in urology: the ileal neobladder.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Radical cystectomy for elderly patients with bladder carcinoma: an updated experience with 404 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

A Systematic Overview of Radiation Therapy Effects in Urinary Bladder Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Extraperitoneal bilateral cutaneous ureterostomy with midline stoma for palliation of pelvic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Transurethral resection of muscle-invasive bladder cancer: 10-year outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: what we do not know and why.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Muscle-invasive urothelial carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Follow-up strategies and management of recurrence in urologic oncology bladder cancer: invasive bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Indications for urethrectomy in an era of continent urinary diversion

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Urethral recurrence after cystoprostatectomy: implications for urinary diversion and monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Treatment of urethral recurrence following radical cystectomy and ileal bladder substitution.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

The management of urethral transitional cell carcinoma after radical cystectomy for invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

Value of urethral wash cytology in the retained male urethra after radical cystoprostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2810%2970010-3

7 January 2021

10.1016/S0210-4806(10)70010-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20223133%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference